367 related articles for article (PubMed ID: 6804162)
1. A randomized, double-blind study of two combined and two progestogen-only oral contraceptives.
Sheth A; Jain U; Sharma S; Adatia A; Patankar S; Andolsek L; Pretnar-Darovec A; Belsey MA; Hall PE; Parker RA; Ayeni S; Pinol A; Li Hoi Foo C
Contraception; 1982 Mar; 25(3):243-52. PubMed ID: 6804162
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind study of six combined oral contraceptives.
Contraception; 1982 Mar; 25(3):231-41. PubMed ID: 6804161
[TBL] [Abstract][Full Text] [Related]
3. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study.
Masson S; Franssen E; Hilditch JR; Powell MG
Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001
[TBL] [Abstract][Full Text] [Related]
4. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Wilson ES; Cruickshank J; McMaster M; Weir RJ
Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception.
Contraception; 1980 May; 21(5):445-59. PubMed ID: 7428356
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind trial of two low dose combined oral contraceptives.
Bounds W; Vessey M; Wiggins P
Br J Obstet Gynaecol; 1979 Apr; 86(4):325-9. PubMed ID: 373792
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new triphasic oral contraceptive in private practice.
Ellsworth HS; Ayerst RI; Harris JW; Stone RA; Anderson AE; Jones TL; Curtis MK
Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161
[TBL] [Abstract][Full Text] [Related]
8. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
9. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
Carlborg L
Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
[TBL] [Abstract][Full Text] [Related]
10. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Akerlund M; Røde A; Westergaard J
Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
Gaspard UJ; Deville JL; Dubois M
Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157
[TBL] [Abstract][Full Text] [Related]
12. Lipid and biochemical changes after low-dose oral contraception.
Loke DF; Ng CS; Holck S; Hall PE; Ratnam SS
Contraception; 1992 Sep; 46(3):227-41. PubMed ID: 1451519
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
[TBL] [Abstract][Full Text] [Related]
14. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
Russowsky M; Sartoretto JN
Contraception; 1982 Jul; 26(1):41-9. PubMed ID: 7128133
[TBL] [Abstract][Full Text] [Related]
15. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of two low-dose combined oral contraceptives: results from a multicenter trial.
Dunson TR; McLaurin VL; Israngkura B; Leelapattana B; Mukherjee R; Perez-Palacios G; Saleh AA
Contraception; 1993 Aug; 48(2):109-19. PubMed ID: 8403908
[TBL] [Abstract][Full Text] [Related]
17. A comparison of high-dose estrogens versus low-dose ethinylestradiol and norgestrel combination in postcoital interception: a study in 493 women.
Van Santen MR; Haspels AA
Fertil Steril; 1985 Feb; 43(2):206-13. PubMed ID: 3881294
[TBL] [Abstract][Full Text] [Related]
18. Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone.
Endrikat J; Hite R; Bannemerschult R; Gerlinger C; Schmidt W
Contraception; 2001 Jul; 64(1):3-10. PubMed ID: 11535206
[TBL] [Abstract][Full Text] [Related]
19. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.
Bannemerschult R; Hanker JP; Wünsch C; Fox P; Albring M; Brill K
Contraception; 1997 Nov; 56(5):285-90. PubMed ID: 9437556
[TBL] [Abstract][Full Text] [Related]
20. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
Kirkman RJ; Pedersen JH; Fioretti P; Roberts HE
Contraception; 1994 Jan; 49(1):33-46. PubMed ID: 8137624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
